Skip to main content

Part of the book series: Serono Symposia, USA ((SERONOSYMP))

  • 97 Accesses

Abstract

A unique disfigurement of acromegaly was seen in ancient paintings or statues, but the association of pituitary enlargement with this disease was first noted by Pierre Marie. Its association with growth hormone (GH) hypersecretion was suggested by Cushing and later confirmed by bioassay and radioimmunoassay (RIA). Since then, RIA has been extensively used in the diagnosis and evaluation of treatment of acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beck C, Larkins RG, Martin TJ, et al. Stimulation of growth hormone release from superfused rat pituitary by extracts of hypothalamus and of human lung tumours. J Endocrinol 1973; 59: 325–33.

    Article  PubMed  CAS  Google Scholar 

  2. Asa SL, Scheithauer BW, Bilbao JM, et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 1984; 58: 796–803.

    Article  PubMed  CAS  Google Scholar 

  3. Scheithauer BW, Kovacs K, Randall RV, et al. Pathology of excessive production of growth hormone. Clin Endocrinol Metab 1986; 15: 665–81.

    Article  Google Scholar 

  4. 1980 Annual Report of Study Group on Hypothalamopituitary Diseases supported by Ministry of Health and Welfare, 1980:15–24.

    Google Scholar 

  5. Imura H, Kato Y, Ishikawa E. Growth hormone secretion in acromegaly. In: Robbins R, Melmed S, eds. Acromegaly: a century of scientific and clinical progress. New York: Plenum Press, 1987: 83–95.

    Google Scholar 

  6. Kashio Y, Chihara K, Kaji H, et al. Presence of growth hormone- releasing factor-like immunoreactivity in human cerebrospinal fluid. J Clin Endocrinol Metab 1985; 60: 396–8.

    Article  PubMed  CAS  Google Scholar 

  7. Matsushita N, Kato Y, Katakami H, et al. Stimulation of growth hormone release by vasoactive intestinal polypeptide from human pituitary adenoma in vitro. J Clin Endocrinol Metab 1981; 53: 1297–300.

    Article  PubMed  CAS  Google Scholar 

  8. Ishibashi M, Yamaji T. Direct effects of catecholamines, thyrotropin-releasing hormone and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pitu¬itary cells in culture. J Clin Invest 1984; 73: 66–78.

    Article  PubMed  CAS  Google Scholar 

  9. Clemmons DR, Van Wyk JJ, Ridgway EC, et al. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979; 301: 1138–42.

    Article  PubMed  CAS  Google Scholar 

  10. Hattori N, Kato Y, Murakami Y, et al. Measurement of urine human growth hormone levels by ultra-highly sensitive enzyme immunoassay. Folia Endocrinol Jpn (in press).

    Google Scholar 

  11. Hashida S, Ishikawa E, Nakagawa K, et al. Demonstration of human growth hormone in normal urine by a highly specific and sensitive sandwich enzyme immunoassay. Anal Lett 1985; 18: 1623–34

    Article  CAS  Google Scholar 

  12. Hashida S, Nakagawa K, Ishikawa E, et al. Basal level of human growth hormone (hGH) in normal serum. Clin Chim Acta 1985; 151: 185–6.

    Article  PubMed  CAS  Google Scholar 

  13. Grossman A, Ross R, Wass JAH, et al. Depot-bromocriptine treatment for prolactinomas and acromegaly. Clin Endocrinol 1986; 24: 231–8.

    Article  CAS  Google Scholar 

  14. Ishibashi M, Fukushima I, Yamaji T. Cyproheptadine-mediated inhibition of growth hormone and prolactin release from pituitary adenoma cells of acromegaly and gigantism in culture. Acta Endocrinol (Copenh) 1985; 109: 474–80.

    CAS  Google Scholar 

  15. Lamberts SWJ, Uilterlinden P, Verschoor L, et al. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. N Engl J Med 1985; 313: 1576–80.

    Article  PubMed  CAS  Google Scholar 

  16. Tolis G, Yotis A, del Pozo E, et al. Therapeutic efficacy of somatostatin analogue (SMS 201-995) in active acromegaly. J Neurosurg 1986; 65: 37–40.

    Article  PubMed  CAS  Google Scholar 

  17. Barnard LB, Grantham WG, Lamberton P, et al. Treatment of resistant acromegaly with a long-acting somatostatin. Ann Intern Med 1986; 105: 856–61.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Plenum Press, New York

About this chapter

Cite this chapter

Imura, H., Kato, Y., Hattori, N. (1988). Acromegaly. In: Bercu, B.B. (eds) Basic and Clinical Aspects of Growth Hormone. Serono Symposia, USA. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5505-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-5505-2_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-5507-6

  • Online ISBN: 978-1-4684-5505-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics